Henan Taloph Pharmaceutical Stock Co Ltd (SHG:600222) — Stock Price

CN¥7.81 CNY
▼ -0.13% today

Henan Taloph Pharmaceutical Stock Co Ltd (SHG:600222) is currently trading at CN¥7.81 CNY, down 0.13% today. Over the past 52 weeks, shares have ranged between CN¥6.26 and CN¥8.70. This page tracks Henan Taloph Pharmaceutical Stock Co Ltd's live share price on the SHG exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Henan Taloph Pharmaceutical Stock Co Ltd market capitalisation.

Henan Taloph Pharmaceutical Stock Co Ltd (600222) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Henan Taloph Pharmaceutical Stock Co Ltd's daily closing share price and trading volume on the SHG exchange over the past year, giving a clear view of recent price momentum and liquidity.

Henan Taloph Pharmaceutical Stock Co Ltd Income Statement — Revenue, Profit & Earnings by Year

Henan Taloph Pharmaceutical Stock Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue CN¥1.76 Billion CN¥1.94 Billion CN¥2.07 Billion CN¥1.96 Billion CN¥1.60 Billion
Cost of Revenue CN¥1.27 Billion CN¥1.44 Billion CN¥1.51 Billion CN¥1.49 Billion CN¥1.15 Billion
Gross Profit CN¥492.23 Million CN¥500.10 Million CN¥561.55 Million CN¥468.40 Million CN¥456.85 Million
Research & Development CN¥67.78 Million CN¥100.89 Million CN¥127.71 Million CN¥116.52 Million CN¥56.50 Million
SG&A CN¥104.81 Million CN¥136.65 Million CN¥141.64 Million CN¥134.48 Million CN¥115.61 Million
Total Operating Expenses CN¥1.59 Billion CN¥464.38 Million CN¥517.38 Million CN¥539.18 Million CN¥421.24 Million
Operating Income CN¥162.83 Million CN¥35.72 Million CN¥44.17 Million CN¥-70.78 Million CN¥35.61 Million
EBITDA — CN¥147.61 Million CN¥95.17 Million CN¥30.16 Million CN¥57.15 Million
EBIT — CN¥96.31 Million CN¥43.88 Million CN¥-17.08 Million CN¥13.16 Million
Interest Expense CN¥55.43 Million CN¥61.23 Million CN¥917.43K CN¥65.77 Million CN¥87.11 Million
Income Before Tax CN¥77.51 Million CN¥35.07 Million CN¥42.96 Million CN¥-82.85 Million CN¥7.45 Million
Income Tax Expense — CN¥-18.42 Million CN¥-1.87 Million CN¥-7.09 Million CN¥671.40K
Net Income CN¥60.00 Million CN¥50.53 Million CN¥43.56 Million CN¥-72.20 Million CN¥6.00 Million

Henan Taloph Pharmaceutical Stock Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Henan Taloph Pharmaceutical Stock Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets CN¥3.64 Billion CN¥3.49 Billion CN¥3.58 Billion CN¥3.60 Billion CN¥3.78 Billion
Total Current Assets CN¥2.14 Billion CN¥1.91 Billion CN¥1.99 Billion CN¥2.03 Billion CN¥1.94 Billion
Cash & Equivalents — — — — —
Short-term Investments CN¥100.02 Million CN¥80.02 Million CN¥153.30 Million CN¥74.96 Million CN¥285.67 Million
Net Receivables CN¥990.55 Million CN¥1.17 Billion CN¥1.06 Billion CN¥1.09 Billion CN¥800.76 Million
Inventory CN¥353.83 Million CN¥367.67 Million CN¥455.50 Million CN¥450.49 Million CN¥381.85 Million
Property, Plant & Equipment — — — — CN¥539.58 Million
Goodwill CN¥286.49 Million CN¥286.49 Million CN¥286.49 Million CN¥286.49 Million CN¥286.49 Million
Total Liabilities CN¥1.98 Billion CN¥1.86 Billion CN¥1.95 Billion CN¥1.99 Billion CN¥2.01 Billion
Total Current Liabilities CN¥1.87 Billion CN¥1.79 Billion CN¥1.65 Billion CN¥1.73 Billion CN¥1.65 Billion
Long-term Debt CN¥61.76 Million CN¥3.02 Million CN¥183.80 Million CN¥192.80 Million CN¥20.37 Million
Net Debt CN¥345.67 Million CN¥498.45 Million CN¥622.64 Million CN¥346.21 Million CN¥795.69 Million
Total Stockholder Equity CN¥1.60 Billion CN¥1.57 Billion CN¥1.58 Billion CN¥1.57 Billion CN¥1.66 Billion
Retained Earnings CN¥343.53 Million CN¥258.45 Million CN¥230.10 Million CN¥186.61 Million CN¥181.24 Million

Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Henan Taloph Pharmaceutical Stock Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow CN¥47.16 Million CN¥-39.59 Million CN¥43.74 Million CN¥-124.41 Million CN¥99.66 Million
Capital Expenditures CN¥21.12 Million CN¥37.23 Million CN¥43.13 Million CN¥66.62 Million CN¥39.07 Million
Free Cash Flow CN¥26.04 Million CN¥-76.82 Million CN¥604.34K CN¥-191.03 Million CN¥60.58 Million
Investing Cash Flow — CN¥18.25 Million CN¥-150.02 Million CN¥134.12 Million CN¥-100.16 Million
Financing Cash Flow — CN¥-9.78 Million CN¥26.56 Million CN¥-85.23 Million CN¥-156.58 Million
Dividends Paid CN¥-50.76 Million CN¥69.07 Million CN¥50.17 Million CN¥5.63 Million CN¥84.56 Million
Stock-Based Compensation — — — — —
Depreciation CN¥64.37 Million CN¥64.94 Million CN¥67.93 Million CN¥67.93 Million CN¥60.50 Million
Change in Cash CN¥31.95 Million CN¥-31.11 Million CN¥-79.72 Million CN¥-75.51 Million CN¥-157.08 Million

Henan Taloph Pharmaceutical Stock Co Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Henan Taloph Pharmaceutical Stock Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 29, 2023 0.01 — —
Oct 29, 2022 -0.06 — —
Aug 20, 2022 -0.05 — —
Apr 29, 2022 0.00 — —
Oct 30, 2021 0.00 — —
Aug 28, 2021 0.00 — —
Apr 29, 2021 0.01 — —
Oct 31, 2020 0.00 — —